Ampicillin/sulbactam
Combination antibiotic drug / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Ampicillin/sulbactam?
Summarize this article for a 10 year old
Ampicillin/sulbactam is a fixed-dose combination medication of the common penicillin-derived antibiotic ampicillin and sulbactam, an inhibitor of bacterial beta-lactamase. Two different forms of the drug exist. The first, developed in 1987 and marketed in the United States under the brand name Unasyn, generic only outside the United States, is an intravenous antibiotic. The second, an oral form called sultamicillin, is marketed under the brand name Ampictam outside the United States, and generic only in the United States. Ampicillin/sulbactam is used to treat infections caused by bacteria resistant to beta-lactam antibiotics. Sulbactam blocks the enzyme which breaks down ampicillin and thereby allows ampicillin to attack and kill the bacteria.
This article needs additional citations for verification. (December 2014) |
Combination of | |
---|---|
Ampicillin | Penicillin antibiotic |
Sulbactam | Beta-lactamase inhibitor |
Clinical data | |
Pronunciation | am pi sill' in and sul bak' tam |
Trade names | Unasyn |
AHFS/Drugs.com | Monograph |
MedlinePlus | a693021 |
Routes of administration | Intramuscular, intraveneous |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG | |
NY (what is this?) (verify) |